Prevention interventions for human immunodeficiency virus in drug-using women with a history of partner violence.

Jamila K Stockman, Natasha Ludwig-Barron, Monica A Hoffman, Monica D Ulibarri, Typhanye V Penniman Dyer
Author Information
  1. Jamila K Stockman: Division of Global Public Health, Department of Medicine, San Diego, La Jolla, CA.
  2. Natasha Ludwig-Barron: Division of Global Public Health, Department of Medicine, San Diego, La Jolla, CA.
  3. Monica A Hoffman: Department of Communication and Science Studies, San Diego, La Jolla, CA.
  4. Monica D Ulibarri: Department of Psychiatry, University of California, San Diego, La Jolla, CA.
  5. Typhanye V Penniman Dyer: Department of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, USA.

Abstract

The intersecting epidemics of human immunodeficiency virus (HIV) and partner violence disproportionately affect women who use drugs. Despite accumulating evidence throughout the world linking these epidemics, HIV prevention efforts focused on these synergistic issues as well as underlying determinants that contribute to the HIV risk environment (eg, housing instability, incarceration, policing practices, survival sex) are lacking. This article highlights selected behavior change theories and biomedical approaches that have been used or could be applied in HIV prevention interventions for drug-using women with histories of partner violence and in existing HIV prevention interventions for drug-using women that have been gender-focused while integrating histories of partner violence and/or relationship power dynamics. To date, there is a paucity of HIV prevention interventions designed for drug-using women (both in and outside of drug treatment programs) with histories of partner violence. Of the few that exist, they have been theory-driven, culture-specific, and address certain aspects of gender-based inequalities (eg, gender-specific norms, relationship power and control, partner violence through assessment of personal risk and safety planning). However, no single intervention has addressed all of these issues. Moreover, HIV prevention interventions for drug-using women with histories of partner violence are not widespread and do not address multiple components of the risk environment. Efficacious interventions should target individuals, men, couples, and social networks. There is also a critical need for the development of culturally tailored combination HIV prevention interventions that not only incorporate evidence-based behavioral and biomedical approaches (eg, microbicides, pre-exposure prophylaxis, female-initiated barrier methods) but also take into account the risk environment at the physical, social, economic and political levels. Ultimately, this approach will have a significant impact on reducing HIV infections among drug-using women with histories of partner violence.

Keywords

References

  1. Sex Transm Infect. 2009 Dec;85(7):555-60 [PMID: 19625287]
  2. J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S101-9 [PMID: 18089979]
  3. Womens Health Issues. 1998 Mar-Apr;8(2):112-22 [PMID: 9542466]
  4. Subst Use Misuse. 2008 Jul;43(8-9):1186-201 [PMID: 18649238]
  5. AIDS Behav. 2006 Mar;10(2):131-7 [PMID: 16482408]
  6. Soc Sci Med. 1994 Oct;39(7):931-48 [PMID: 7992126]
  7. Am J Public Health. 2009 Jun;99(6):996-1001 [PMID: 19372518]
  8. Int Fam Plan Perspect. 2004 Sep;30(3):139-45 [PMID: 15381469]
  9. Drug Alcohol Depend. 2010 Jun 1;109(1-3):205-12 [PMID: 20219294]
  10. J Womens Health (Larchmt). 2010 Sep;19(9):1705-13 [PMID: 20662629]
  11. BMJ. 2005 Jul 23;331(7510):220-3 [PMID: 16037463]
  12. AIDS Care. 2008 Feb;20(2):228-34 [PMID: 18293134]
  13. Am J Public Health. 2000 Sep;90(9):1377-81 [PMID: 10983187]
  14. J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S17-22 [PMID: 21045594]
  15. Subst Use Misuse. 2011;46(2-3):295-306 [PMID: 21303249]
  16. J Urban Health. 2006 Jul;83(4):575-85 [PMID: 16845496]
  17. N C Med J. 2010 Sep-Oct;71(5):477-81 [PMID: 21473554]
  18. Int J Drug Policy. 2008 Apr;19(2):130-9 [PMID: 18207723]
  19. J Midwifery Womens Health. 2006 Nov-Dec;51(6):478-85 [PMID: 17081939]
  20. J Urban Health. 2007 Jul;84(4):508-22 [PMID: 17356904]
  21. Lancet. 2008 Nov 15;372(9651):1733-45 [PMID: 18817968]
  22. Am J Health Promot. 1992 Jan-Feb;6(3):197-205 [PMID: 10146784]
  23. Curr Opin HIV AIDS. 2011 Mar;6(2):114-8 [PMID: 21505385]
  24. Am J Community Psychol. 2001 Dec;29(6):937-64 [PMID: 11800513]
  25. Int J Pediatr. 2011;2011:389285 [PMID: 21541069]
  26. AIDS Behav. 2004 Dec;8(4):429-39 [PMID: 15690116]
  27. Int J Addict. 1976;11(1):19-33 [PMID: 767261]
  28. Soc Sci Med. 2005 Jul;61(1):171-83 [PMID: 15847970]
  29. Am J Public Health. 2009 Nov;99(11):2069-78 [PMID: 19762676]
  30. Am Psychol. 1995 Jun;50(6):437-47 [PMID: 7598292]
  31. Lancet. 2008 Aug 16;372(9638):585-99 [PMID: 18687456]
  32. Public Health Nurs. 2011 Jul-Aug;28(4):366-78 [PMID: 21736615]
  33. AIDS Educ Prev. 2008 Apr;20(2):107-20 [PMID: 18433317]
  34. Curr HIV/AIDS Rep. 2011 Mar;8(1):62-72 [PMID: 20941553]
  35. Sex Transm Infect. 2005 Jun;81(3):193-200 [PMID: 15923284]
  36. Curr HIV/AIDS Rep. 2011 Jun;8(2):94-103 [PMID: 21465112]
  37. PLoS One. 2011;6(8):e17502 [PMID: 21826193]
  38. Am J Public Health. 2004 Jul;94(7):1165-73 [PMID: 15226138]
  39. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):581-9 [PMID: 18645513]
  40. Soc Sci Med. 2008 Feb;66(4):911-21 [PMID: 18155336]
  41. Health Educ Behav. 2000 Oct;27(5):539-65 [PMID: 11009126]
  42. Am J Community Psychol. 1995 Oct;23(5):569-79 [PMID: 8851340]
  43. AIDS Behav. 2003 Dec;7(4):339-51 [PMID: 14707531]
  44. AIDS Behav. 2003 Mar;7(1):73-86 [PMID: 14534392]
  45. J Womens Health Gend Based Med. 2000 Dec;9(10):1071-80 [PMID: 11153103]
  46. Am J Drug Alcohol Abuse. 2009;35(5):295-300 [PMID: 19591066]
  47. AIDS Care. 2006 Jan;18(1):1-11 [PMID: 16282070]
  48. J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S98-101 [PMID: 21406997]
  49. Am J Public Health. 2005 Mar;95(3):465-70 [PMID: 15727978]
  50. Trends Pharmacol Sci. 2010 Feb;31(2):74-81 [PMID: 19963288]
  51. Lancet. 2010 Jul 31;376(9738):312-4 [PMID: 20650519]
  52. Women Health. 2010 Mar;50(2):107-24 [PMID: 20437300]
  53. Curr HIV/AIDS Rep. 2010 Nov;7(4):185-93 [PMID: 20730512]
  54. Public Health Rep. 2001 Sep-Oct;116(5):434-48 [PMID: 12042608]
  55. Violence Vict. 2006 Oct;21(5):657-72 [PMID: 17022356]
  56. Am J Public Health. 2007 Oct;97(10):1794-802 [PMID: 17761566]
  57. Lancet. 2010 Jul 24;376(9737):268-84 [PMID: 20650523]
  58. Am J Public Health. 2006 Oct;96(10):1873-8 [PMID: 16670216]
  59. Subst Use Misuse. 2003 Jun;38(8):1133-58 [PMID: 12901452]
  60. Science. 2010 Sep 3;329(5996):1168-74 [PMID: 20643915]
  61. AIDS Educ Prev. 2003 Feb;15(1):15-32 [PMID: 12627741]
  62. Antiviral Res. 2010 Dec;88 Suppl 1:S3-9 [PMID: 21109065]
  63. Drugs. 2010 Jul 9;70(10):1231-43 [PMID: 20568831]
  64. PLoS Med. 2005 May;2(5):e142 [PMID: 15916473]

Grants

  1. K01 DA026307/NIDA NIH HHS
  2. R25 DA025571/NIDA NIH HHS
  3. K01 DA031593/NIDA NIH HHS
  4. K01 DA031593-01/NIDA NIH HHS
  5. R25 MH080664/NIMH NIH HHS
  6. R25 MH080664-02/NIMH NIH HHS
  7. L60 MD003701-02/NIMHD NIH HHS
  8. L60 MD003701/NIMHD NIH HHS
  9. T32 DA023356/NIDA NIH HHS
  10. R25 DA025571-02/NIDA NIH HHS

Word Cloud

Created with Highcharts 10.0.0HIVpartnerviolencewomeninterventionspreventiondrug-usinghistoriesriskhumanimmunodeficiencyvirusenvironmentegepidemicsdrugsissuesbiomedicalapproachesrelationshippoweraddressgender-basedinequalitiessocialalsointersectingdisproportionatelyaffectuseDespiteaccumulatingevidencethroughoutworldlinkingeffortsfocusedsynergisticwellunderlyingdeterminantscontributehousinginstabilityincarcerationpolicingpracticessurvivalsexlackingarticlehighlightsselectedbehaviorchangetheoriesusedappliedexistinggender-focusedintegratingand/ordynamicsdatepaucitydesignedoutsidedrugtreatmentprogramsexisttheory-drivenculture-specificcertainaspectsgender-specificnormscontrolassessmentpersonalsafetyplanningHoweversingleinterventionaddressedMoreoverwidespreadmultiplecomponentsEfficacioustargetindividualsmencouplesnetworkscriticalneeddevelopmentculturallytailoredcombinationincorporateevidence-basedbehavioralmicrobicidespre-exposureprophylaxisfemale-initiatedbarriermethodstakeaccountphysicaleconomicpoliticallevelsUltimatelyapproachwillsignificantimpactreducinginfectionsamongPreventionhistoryacquiredimmunedeficiencysyndrome

Similar Articles

Cited By